Tezepelumab, a monoclonal antibody targeting TSLP approved for add-on severe asthma treatment in 2021, had been associated ...

In severe asthma, most patients who seek acute care do so due to symptom severity and need for rapid care when rescue ...

If you or someone you know has chronic asthma do read this article to know how biologics can potentially help in treating the condition ...

AstraZeneca presented data from the phase 3 BATURA study which showed that use of Airsupra in those with mild asthma reduced ...

Remote study conducted at Rutgers and elsewhere finds albuterol-budesonide mix cuts risk for mild cases and may let patients ...

Dr. Vikas Mittal shares these tips to manage asthma flare-ups: 1. Stay calm and manage anxiety: The first step during a flare ...

The following is a summary of “Severe Asthma Questionnaire (SAQ) and Asthma Control Questionnaire (ACQ) as Early Predictors ...

As-needed albuterol-budesonide yields a lower risk for severe asthma exacerbation among patients with mild asthma, according ...

All participants will initially undergo a run-in period on standardised medium-dose ICS/LABA to confirm persistent lack of ...

New findings suggest asthma may be reversible in some cases, offering hope for long-term remission and a shift in treatment ...

AstraZeneca (LSE:AZN) recently announced that its AIRSUPRA therapy significantly reduced severe asthma exacerbations, ...

The risk for fertility treatment rose among women with vs. without asthma, and those with severe asthma and past ...